No Detail Found!

May Nesfatin-1 Be a Biomarker in Acute Mesenteric Ischemia?.

Author(s)
Cihad Tatar Departmet of General Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey
Fatih Alper Ahlatci Department of Pathology, Corlu State Hospital, Tekirdag, Turkey
Ufuk Oguz Idiz Departmet of General Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey
Ali Emre Nayci Departmet of General Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey
Said Incir Department of Biochemistry, Koc University, Medical Faculty, Istanbul, Turkey
Orhan Agcaoglu Department of General Surgery, Koc University, Medical Faculty, Istanbul, Turkey
Cemile Idiz Department of Internal Medicine, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey
Emre Balik Department of General Surgery, Koc University, Medical Faculty, Istanbul, Turkey
Abstract
Objective: To investigate the diagnostic value of nesfatin-1 in cases of intestinal ischemia and ischemia/reperfusion. Study Design: An experimental study. Place and Duration of Study: The Experimental Animals Laboratory of Bezmialem University, in June 2018. Methodology: Twenty-one healthy male Sprague Dawley rats were randomly divided into three groups of 7 rats each. In group 1: 1-hour intestinal ischemia followed by 5-hour reperfusion was performed. In group 2: rats were subjected to 6-hour intestinal ischemia. In group 3: rats underwent laparotomy and closure without performing any further procedure. Changes in leukocyte count, amylase, blood sugar, LDH, SGOT, CRP, and nesfatin-1 levels were determined. For histopathological examination, a small intestinal sample was taken and preserved in 10% formaldehyde. Results: Nesfatin-1 value in group 2 was significantly higher than that in group 1 and group 3 (p=0.005, and p <0.001 respectively). Nesfatin-1 value in group 1 was significantly higher than that in group 3. A significant (r = 0.864/p <0.001) positive correlation was observed between nesfatin-1 value and pathology score. The pathology score of group 2 was significantly higher than that of group 1 and group 3 (p <0.001). Conclusion: Serum nesfatin-1 can be a biomarker in acute mesenteric ischemia.
Publication Details
Page(s) 928-931
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 29, Issue: 10, Year: 2019

Request the full text from PASTIC

0

Citations

0

Downloads

73

Views